Intercept Pharmaceuticals | Company Profile - Revenue, Headcount, Tech Stack, Contacts
Intercept Pharmaceuticals, Inc.
Industry & Market
Funding Information
Headcount Distribution
By Department
Department Breakdown
Keywords & Focus Areas
Overview
Intercept Pharmaceuticals, Inc. is a biopharmaceutical company based in Morristown, New Jersey, offering innovative therapeutic solutions for progressive non-viral liver diseases. Established in 2002, the organization is recognized for its research and development of treatments targeting chronic conditions such as primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH).
The company's flagship product, Ocaliva (obeticholic acid), is a first-in-class FXR agonist approved for adult PBC treatment and additionally being developed for diverse liver-related conditions. Intercept continues to expand its therapeutic pipeline with candidates like INT-787 for severe alcohol-associated hepatitis and bezafibrate for potential PBC treatment. Operating as a subsidiary of Alfasigma S.p.A. since 2023, Intercept markets its products across the United States, Europe, and Canada, underscoring its commitment to patient-focused innovation and collaboration within the biopharmaceutical industry.
Key Metrics
Get Complete Company Metrics
Dive deeper into employee structure, funding, revenue, and key performance indicators all in one place.
Contact
Technology Stack
Analytics & Tracking
Social & Marketing
Database & Backend
Cloud & Infrastructure
Productivity
Compare similar companies to Intercept Pharmaceuticals
Compare insights from companies similar to Intercept Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
| Company Name | Revenue | No. of Employees | Type | Funding | Founded In | Top Executive |
|---|---|---|---|---|---|---|
| xxxxxxxxx | $90259 | 91 | Private | - | 2283 | xxxxxxx |
| xxxxx | $538 | 45 | Private | - | 8947 | xx |
| xx | $49962 | 65 | Private | - | 5348 | xxxxxx |
| xxxx | $62547 | 27 | Private | - | 423 | x |
| xxxxxx | $24913 | 26 | Private | - | 3508 | xxxxxxxxxx |
Discover Similar Companies Instantly
Explore detailed insights and analysis on companies related to your search.